包含表皮调节素抑制剂的癌症免疫治疗用抗癌辅助剂及癌症转移抑制用组合物
本发明涉及一种包含表皮调节素(epiregulin;EREG)抑制剂的癌症免疫治疗用抗癌辅助剂及癌症转移抑制用组合物。本发明旨在提供一种组合物,该组合物以肿瘤相关巨噬细胞(TAM)的表皮调节素为靶标,诱导肿瘤相关巨噬细胞的极化变化,具体地,通过调节M2巨噬细胞的亚型来增加M1巨噬细胞的比率,从而具有抑制癌细胞增殖及转移的效果。
APPLICANTS
Browse source applicant names and unchanged name fields from imported patent records.
These are name-based results, not verified legal entities. Identical names may refer to different people or organizations; aliases and historical names are not merged.
This name was extracted from a distinct applicant node in the source XML.
1 indexed patent records
Patent counts refer to distinct records held by this site, not an applicant’s complete portfolio. A joint name field is not a single company.
Verified corpus date coverage and last import time are not currently available. Publication dates on patent records are not import dates. Cached directory results may lag behind new imports.
Search the local original applicant field containing this full text. Results may include joint lists or longer names; this is not an exact identity search.
Search patents with this applicant condition